某IT企业员工非酒精性单纯性脂肪肝和非酒精性脂肪性肝炎的初步调查及特征分析

李秀池; 阮改清; 吕加恩; 孙茉芊; 汪明明

doi:10.3969/j.issn.1001-5256.2017.07.024

某IT企业员工非酒精性单纯性脂肪肝和非酒精性脂肪性肝炎的初步调查及特征分析

DOI: 10.3969/j.issn.1001-5256.2017.07.024

爱康国宾健康体检集团管理有限公司健康管理部

详细信息

中图分类号: R575
计量
- 文章访问数: 2438
- HTML全文浏览量: 86
- PDF下载量: 409
- 被引次数: 0
出版历程
- 收稿日期: 2017-01-03
- 出版日期: 2017-07-20

A preliminary investigation and feature analysis of non-alcoholic fatty liver and nonalcoholic steatohepatitis in employees in an IT company

Department of Health Management, iKang Healthcare Group, Inc., Beijing 100006, China

摘要

摘要:
目的调查和分析非酒精性单纯性脂肪肝和非酒精性脂肪性肝炎的发生率及特点,为相关部门做好健康管理、研究制订干预防范措施提供理论依据。方法调取某大型IT企业2016年7月30日-2016年11月3日的体检报告,分析不同年龄段和不同性别NAFL和NASH的发病率,同时分析与超重（或肥胖）、甘油三酯、空腹血糖、血尿酸和血压等指标的相关性。计数资料的比较采用χ2检验。结果 NAFL和NASH的总发病率分别为4.51%和17.64%,合计22.15%。在NAFLD组（NAFL和NASH）人群中超重（或肥胖）、高血脂和高尿酸的发生率显著高于非NAFLD组（非NAFL和非NASH）人群（91.20%vs 12.68%,χ2=7571.9,P<0.001;95.06%vs 9.27%,χ2=9373.8,P<0.001;40.02%vs 10.51%,χ2=1591.90,P<0.001）;男性员工NAFL和NASH的发生率均显著高于女性员工（6.78%vs 1.81%,χ2=1...
- 脂肪肝 /
- 高脂血症 /
- 高血糖症 /
- 高尿酸血症 /
- 高血压 /
- 肥胖症,病态
Abstract:
Objective To investigate the incidence rates and features of non-alcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) , and to provide a theoretical basis for health management and development of intervention and preventive measures in the health management department.Methods Physical examination reports in 2016 were obtained from a large IT company to analyze the incidence rates of NAFL and NASH in different age and sex groups, as well as the correlation with the indices including overweight (or obesity) , triglyceride, fasting blood glucose, blood uric acid, and blood pressure.The chi-square test was used for comparison of rates.Results In all employees, the incidence rates of NAFL and NASH were 4.51% and 17.64%, respectively, and the overall incidence rate of these two diseases was 22.15%.The NAFL-NASH group had significantly higher incidence rates of overweight (or obesity) (91.20% vs 12.68%, χ2=7571.9, P<0.001) , hyperlipidemia (95.06% vs 9.27%, χ2=9373.8, P<0.001) , and hyperuricemia (40.02% vs 10.51%, χ2=1591.90, P<0.001) than the non-NAFL-NASH group.Compared with female employees, male employees had significantly higher incidence rates of NAFL (6.78% vs 1.81%, χ2=190.35, P<0.001) and NASH (25.04% vs 5.06%, χ2=991.90, P<0.001) , as well as significantly higher incidence rates of overweight (or obesity) (40.90% vs 12.97%, χ2=1319.10, P<0.001) , hyperlipidemia (36.00% vs 16.07%, χ2=696.22, P<0.001) , hyperglycemia (2.17% vs 0.64%, χ2=53.82, P<0.01) , hyperuricemia (26.76%vs 1.69%, χ2=1581.10, P<0.001) , and hypertension (6.21% vs 1.22%, χ2=170.94, P<0.001) .Compared with those aged<35 years, the employees aged ≥35 years had significantly higher incidence rates of NAFL (8.13% vs 4.47%, χ2=41.56, P<0.001) and NASH (21.73% vs 16.76%, χ2=24.72, P<0.001) , as well as significantly higher incidence rates of hyperglycemia (2.79% vs1.43%, χ2=17.26, P<0.001) and hypertension (6.33% vs 4.03%, χ2=18.56, P<0.001) while="" there="" were="" no="" significant="" differences="" in="" the="" incidence="" rates="" of="" overweight="" or="" and="" high="" uric="" acid="" between="" these="" two="" groups="" all="" p="">0.05) .Conclusion Although IT employees are young, there is no significant reduction in the incidence rate of nonalcoholic fatty liver disease.The development of NAFL and NASH has the clinical features of overweight (or obesity) , hyperlipidemia, and hyperuricemia, which are commonly seen in male patients.Older employees have higher incidence rates of NAFL, NASH, hyperglycemia, and hypertension than younger employees.
- fatty liver /
- hyperlipidemias /
- hyperglycemia /
- hyperuricemia /
- hypertension /
- obesity, morbid

HTML全文

参考文献(13)

[1]The Chinese National Work-shop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association.Guidelines for management of nonalcoholic fatty liver disease:an updated and revised edition[J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[2]FAN JG.Research advances in non-alcoholic fatty liver disease:a review of current status and prospect[J].J Clin Hepatol, 2015, 30 (7) :999-1001. (in Chinese) 范建高.非酒精性脂肪性肝病的研究现状与展望[J].临床肝胆病杂志, 2015, 30 (7) :999-1001.

[3]PETTA S, GASTALDELLI A, REBELOS E, et al.Pathophysiology of non alcoholic fatty liver disease[J].Int J Mol Sci, 2016, 17 (12) :120-125.

[4]CARR RM, ORANU A, KHUNGAR V.Nonalcoholic fatty liverdisease:pathophysiology and management[J].Gastroenterol Clin North Am, 2016, 45 (4) :639-652.

[5]FAN JG, YAN SL.Metabolic syndrome and fatty liver[J].J Clin Hepatol, 2016, 32 (3) :407-410. (in Chinese) 范建高, 颜士林.代谢综合征与脂肪肝[J].临床肝胆病杂志, 2016, 32 (3) :407-410.

[6]LIAO HL, XIAO XH.Research advance on mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease[J].J Clin Pathol Res, 2014, 34 (6) :831-836. (in Chinese) 廖海林, 肖新华.甘油三酯在非酒精性脂肪肝沉积的机制研究进展[J].临床与病理杂志, 2014, 34 (6) :831-836.

[7]LISBOA QC, COSTA SM, COUTO CA.Current management of non-alcoholic fatty liver disease[J].Rev Assoc Med, 2016, 62 (9) :872-878.

[8]WU F, HUANG J, CHEN XQ.Clinical analysis of nonalcoholic fatty liver disease[J].Chin J Pract Intern Med, 2016, 36 (Suppl 8) :38-39. (in Chinese) 吴奋, 黄静, 陈湘清.非酒精性脂肪肝临床特征分析[J].中国实用内科杂志, 2016, 36 (Suppl 8) :38-39.

[9]XU BB, WANG BY.Nonalcoholic fatty liver disease and serum uric acid[J].J Clin Hepatol, 2016, 32 (3) :437-441. (in Chinese) 徐贝贝, 王炳元.非酒精性脂肪性肝病与血清尿酸[J].临床肝胆病杂志, 2016, 32 (3) :437-441.

[10]ZHU JZ, HOLLIS-HANSEN K, WAN XY, et al.Clinical guidelines of non-alcoholic fatty liver disease:a systematic review[J].World JGastroenterol, 2016, 22 (36) :8226-8233.

[11]ZENG Q.An introduction to functional medical[M].Beijing:People's Medical Publishing House, 2016:268-310. (in Chinese) 曾强.功能医学概论[M].北京:人民卫生出版社, 2016:268-310.

[12]GAO X, JIN EH.Research progress of liver fatty deposits and type2 diabetes mellitus[J].Chin J Med Offic, 2015, 14 (5) :428-431. (in Chinese) 高翔, 靳二虎.肝脏脂肪沉积与2型糖尿病相关性研究进展[J].临床军医杂志, 2015, 14 (5) :428-431.

[13]JIANG YY, LIU L.The research advances in the treatment of nonalcoholic fatty liver disease[J/CD].Chin J Liver Dis:Electronic E-dition, 2015, 7 (1) :127-128. (in Chinese) 江依勇, 刘丽.非酒精性脂肪肝治疗进展研究[J/CD].中国肝脏病杂志:电子版, 2015, 7 (1) :127-128.

施引文献

资源附件(0)

访问统计